The ESYSTA app and the ESYSTA portal are safe medical products. TüV-Rheinland and MedCert Hamburg audit our ISO 13485 and ISO 27001 certification annually.
The quality and data security of the product, as well as the interoperability of the app, are the focus of the audit process, which ESYSTA has successfully passed, along with other criteria.
As the topic of interoperability is equally important for users and treatment teams, ESYSTA sets standards here.
With standardized interfaces and a selection of compatible devices that is constantly growing, ESYSTA ensures a high level of acceptance among users and treatment teams, gives them flexibility and ensures a future-proof system in the long term.
ESYSTA explicitly invites all potential providers to connect to the ESYSTA system. Some integrations are already being implemented.
Blood glucose meter from aktivmed, available in two versions:
The Bluetooth® interface allows the aktivmed GlucoCheck Gold to automatically transmit blood glucose measurement data to the ESYSTA app.
Blood glucose meter from aktivmed, available in two versions:
The Bluetooth® interface allows the aktivmed GlucoCheck Gold to automatically transmit blood glucose measurement data to the ESYSTA app.
Blood glucose meter from Beurer, available in two versions:
Using the Bluetooth function, the Beurer GL 50 evo can automatically transmit blood glucose measurement data to the ESYSTA app.
Blood glucose meter from Beurer, available in two versions:
Using the Bluetooth function, the Beurer GL 50 evo can automatically transmit blood glucose measurement data to the ESYSTA app.
Blood glucose meter from Roche, available in two versions:
Using the Bluetooth function, the Roche Accu-Chek Guide can automatically transmit blood glucose measurement data to the ESYSTA app.
Blood glucose meter from Roche, available in two versions:
Using the Bluetooth function, the Roche Accu-Chek Guide can automatically transmit blood glucose measurement data to the ESYSTA app.
A direct integration of FreeStyle Libre is planned as soon as the manufacturer provides us with a data interface.
Until then, it is possible to import the data exported from the LibreView portal as a CSV file into the ESYSTA portal.
Please contact us if you need instructions for the import.
A direct integration of FreeStyle Libre is planned as soon as the manufacturer provides us with a data interface.
Until then, it is possible to import the data exported from the LibreView portal as a CSV file into the ESYSTA portal.
Please contact us if you need instructions for the import.
The new ESYSTA BT Pen is equipped with a Bluetooth® interface and transmits the injected insulin doses directly to the ESYSTA app on your smartphone.
The ESYSTA Pen can be used with all common insulins using the appropriate adapter.
The new ESYSTA BT Pen is equipped with a Bluetooth® interface and transmits the injected insulin doses directly to the ESYSTA app on your smartphone.
The ESYSTA Pen can be used with all common insulins using the appropriate adapter.
The NovoPen® 6 smart pen from Novo Nordisk easily transfers insulin delivery information from the pen to your smartphone in the ESYSTA app (DiGA). This allows you to complete your insulin documentation for Novo Nordisk® insulins automatically and without additional effort.
The NovoPen® 6 smart pen from Novo Nordisk easily transfers insulin delivery information from the pen to your smartphone in the ESYSTA app (DiGA). This allows you to complete your insulin documentation for Novo Nordisk® insulins automatically and without additional effort.
The NovoPen Echo® Plus smart pen from Novo Nordisk easily transfers insulin delivery information from the pen to your smartphone in the ESYSTA app (DiGA). This allows you to complete your insulin documentation for Novo Nordisk® insulins automatically and without additional effort.
The NovoPen Echo® Plus smart pen from Novo Nordisk easily transfers insulin delivery information from the pen to your smartphone in the ESYSTA app (DiGA). This allows you to complete your insulin documentation for Novo Nordisk® insulins automatically and without additional effort.
Disclaimer:
ESYSTA has NOT been developed in collaboration with Novo Nordisk A/S, evaluated by Novo Nordisk A/S or endorsed in any way by Novo Nordisk A/S. Compatibility has NOT been evaluated by Novo Nordisk A/S for use with NovoPen® 6 or NovoPen Echo® Plus. EMPERRA GmbH E-Health Technologies is the manufacturer of ESYSTA and is solely responsible for ensuring the safety and performance of ESYSTA for its intended use. Novo Nordisk A/S is in no way responsible for the content or use of ESYSTA or for the accuracy of the data obtained through the use of ESYSTA.
Patients
Doctors
ESYSTA
Languages
Social
Copyright by Empera GmbH E-Health Technologies 2019. All rights reserved.
Copyright by Empera GmbH E-Health Technologies 2019. All rights reserved.
